一种新型C_(18)酯型反相高效液相色谱填料的制备

发展了一种用于制备反相高效液相色谱填料的实用、经济的方法。以γ环氧丙基氧丙基三甲氧基硅烷为中间偶联试剂,将十八烷基脂肪酸键合至硅胶上。元素分析、色谱测试验证了该工艺的可行性和填料的反相色谱行为。     

用于碱性物质分离的酰胺型反相色谱键合相的制备及评价

 采用先对硅胶进行氨丙基化 ,然后与辛酰氯键合的方法 ,在国内首次制备了“内嵌”极性官能团酰胺键的反相色谱填料。以甲醇 水为二元流动相 ,用含有中性、酸性和碱性有机化合物的混合物评价了该固定相的疏水性、选择性和亲硅醇基效应 ,并考察了该填料适用的 pH值范围及水解稳定性。结果表明 ,该固定相具有较好的色谱性能 ,且在 pH 2 5～ 7 5时稳定性能良好 ,可有效地用于碱性化合物的分离分析。     

限进介质烷基-二醇基硅胶(ADS)的制备

 烷基 二醇基硅胶 (ADS)系限进介质的一种 ,可用于含生物大分子的复杂生物样品的直接进样与分析。一种新的、非常经济的方法可用于烷基 二醇基硅胶的制备。首先 ,将γ 环氧丙基氧丙基三甲氧基硅烷基键合至微孔硅胶上 (粒度 5 μm ,孔径 6nm)以制备环氧基硅胶 ,再令环氧基硅胶与硬脂酸在有机溶液中进行反应以制备酯型十八烷基反相填料。将制得的反相填料填充至色谱柱中 ,并令含有酯酶的溶液通过色谱柱。通过酶解作用可将硅胶表面的酯基除去 ,而硅胶的内孔表面仍保持疏水特性不变 ,这是由于硅胶上的小孔对酶分子具有体积排除作用。     

二乙烯苯与乙烯基吡咯烷酮共聚硅质填料的制备及对蛋白质的分离

大孔硅胶基质与二乙氧基甲基乙烯基硅烷反应后，再与二乙烯，乙烯基吡咯烷酮共聚，制得新型反相色谱填料。实验结果表明，该填料对蛋白质的分离性能好，柱效高，速度快，惰性好。为生物大分子的高效液相色谱分离提供了一种新型填料。     

有机氟键合相高效液体色谱填料的研究——Ⅳ.1,1,2,2-四氢-7-三氟甲基十二氟辛基键合相填料

在研究了以全氟辛酰胺丙基三乙氧基硅烷与硅胶反应制得的键合相高效液体色谱用填料(FN-YWG)的基础上^[1-4],我们又制备了以1,1,2,2-四氢-7-三氟甲基十二氟辛基三氯硅烷作为改性剂与硅胶反应的另一种含氟的氟烃键合相填料,控制其有机层的键合量制备了既可用于正相又可用于反相色谱的填料.     

大孔硅胶聚合物键合相的制备及其在蛋白质分离中的应用

大孔硅胶与乙烯基硅烷反应后，再与甲基 丙烯酸羟乙基酯和二乙烯基苯共聚成一种新型分离蛋白质的反相色谱填料。     

十八烷基醚型高效液相反相色谱填料的制备

反相填料在生物学、化学和药物工业等领域应用广泛 ,大量新的性能优良的反相柱不断投入市场[1,2 ].反相固定相除选择烷基链长度在Ｃ1Ｃ18之间外 ,不同疏水配基及结构特征也可提供不同的选择性 .通常调节流动相的组成 ,可以实现对分离过程的优化 ,但在实际应用中 ,发展不同类型的柱可更有效地分离相似或相近的化合物[3 ,4].本文报道了一种制备Ｃ18烷基醚型反相ＨＰＬＣ填料的新工艺[5 ],并对所得填料进行了初步的色谱性能评价 .1　实验部分1 .1　试剂与仪器　自制球形硅胶 (Ｓｉｎｏｐａｋ Ｓ ,粒径 5μｍ ,平均孔径 1 1ｎｍ ,比表面积 1 70…     

天冬酰胺修饰硅胶极性固定相的制备

硅胶是最常用的色谱固定相填料.毛细管电色谱(CEC)广泛地使用反相硅胶填料分离中性和非极性物质.极性和碱性物质由于在反相填料上色谱保留很小或不保留,对这些物质的分离长期以来一直是毛细管电色谱反相分离模式的挑战~([1,2]).     

一种新型极性脲丙基-C30固定相的制备和性能评价

以3-脲丙基三甲氧基硅烷为偶联剂，制备了一种新型极性脲丙基-C30（TPU-C30）反相色谱固定相。采用扫描电子显微镜、元素分析、红外光谱和热分析等对该固定相进行表征。结果表明，TPU-C30固定相已成功制备，连续制备3次固定相，其元素含量的相对偏差均小于5%，说明该合成工艺重复性良好。以不同极性、位置异构、碱性化合物为溶质探针，以传统的C18色谱柱与C30色谱柱为参比，对制备的固定相的色谱性能进行了研究。研究结果表明，TPU-C30固定相具有不同于传统C18柱、C30柱的选择性和更优的择形性，明显改善了碱性物质的峰形，其具有广阔的应用空间。     

聚4-甲基-5-乙烯基噻唑键合硅胶柱的选择性研究

较为系统地研究了聚4甲基5乙烯基噻唑键合硅胶固定相(PMVCAphase)与C18,C8及苯基柱在反相色谱中甲醇水体系下的选择性差别。结果表明,该固定相与常用反相色谱固定相有相似性,显示了一般反相色谱固定相填料的特性;另一方面,又由于其特殊结构,更多地显示了其在反相色谱上的特殊选择性。     

Automated trace enrichment for screening and/or determination of primary, secondary and tertiary amphetamines in biological samples by liquid chromatography

A rapid and simple liquid chromatographic method for the automated determination of amphetamines in biological fluids was developed. The proposed procedure is based on the injection of 250 microL of sample into a 20 x 2.1 mm id precolumn (packed with a 30 microns Hypersil C18 stationary phase) for enrichment and purification of the analytes. Next, the analytes are transferred to a 5 microns LiChrospher 100 RP18, 125 x 4 mm id analytical column for their separation under reversed-phase conditions. Water was used to eliminate the matrix components from the precolumn and a 0.2 M phosphate buffer (pH 3) containing 2% triethylamine was the mobile phase for the resolution of the amphetamines. The UV detector was set at 210 nm. The method was applied to the determination of different primary, secondary and tertiary amphetamines in plasma and urine: beta-phenylethylamine, norephedrine, ephedrine, N-methylpseudoephedrine, pseudoephedrine, N-methylephedrine, amphetamine, 3-phenylpropylamine and methamphetamine. The method provides satisfactory linearity and reproducibility within the tested concentration range (1.0-10.0 micrograms mL-1) and limits of detection of 50-500 ng/mL-1.     

Determination of the novel hydroxymethyl glutaryl coenzyme A reductase inhibitor (RP 61969) and its dihydroxy acid hydrolysis product in human plasma by reversed-phase high-performance liquid chromatography.

A method is described for the determination of the novel hydroxymethyl glutaryl coenzyme A reductase inhibitor RP 61969 (I) and its hydrolysis product, the dihydroxy acid RP 62420 (II), in human plasma. A structural isomer of I is used as internal standard. Both I and II were extracted from acidified plasma with diethyl ether. The dried residues were reconstituted in the high-performance liquid chromatography mobile phase and chromatographed on a 5 microns ODS2 column. The mobile phase used was aqueous dipotassium phosphate +tetra-n-butyl ammonium bromide (both 10 mM)-acetonitrile-methanol (60:40:5, v/v). At a flow-rate of 1.5 ml min-1 and ambient temperature, the retention time of II is 3.5 min, that of the internal standard is 5 min, and that of I is 8 min. The method has been validated and applied to the assay of plasma samples resulting from a cell-plasma distribution experiment in human whole blood.     

利用后凝胶化反应制备低吸附性反相填料

在硅胶基质的反相填料 (如 C18、C8、C4 等 )上 ,蛋白质的变性 ,碱性分子峰展宽、拖尾甚至完全吸附等常被归因为硅羟基产生的次级效应 (Secondary Effect) [1～ 3] .我们认为 ,除填料的孔径效应外 [4 ] ,杂质离子与残余硅羟基的协同效应是导致此类问题的直接原因 ,如金属离子直接作用于溶质以及金属离子和硅羟基的远程作用力导致的溶质变性等 .为解决这一问题 ,可采用高反应性的新硅烷化试剂 ,以尽可能将硅羟基完全屏蔽 [5] ,或以封端试剂消除残余的硅羟基 .但是 ,用硅烷化试剂封端 (End-capping)在多数情况下并不能完全覆盖表面硅羟基 ,…     

亚微米中孔SBA-15 棒状固定相在毛细管电色谱分离中的应用(英文)

采用中孔SBA-15棒状硅胶颗粒填充毛细管柱用于毛细管电色谱(CEC)分离。这一亚微米材料直径为400 nm并具有沿相同方向伸展的高度有序、均一的圆柱形中孔。棒状的特殊形态使得填充柱的通透性良好,简化了尺寸微小的CEC柱的填充过程。修饰后的棒状SBA-15填充毛细管柱成功应用于反相和离子交换电色谱分离非极性和极性样品,获得了较高柱效(140000理论塔板/m)。流速3.2cm/min时获得最低理论塔板高度为7.1 mm。范迪米特曲线说明了SBA-15孔结构的传质阻力特征。分别以芳香酸、人参、天麻提取物为样品,对亚微米固定相毛细管电色谱柱加以评价。该固定相显示出了较高的分离能力,为纳米材料在色谱固定相中的应用提供了一个新的思路。     

High-performance liquid chromatographic determination of rifapentine in serum using column switching.

A high-performance liquid chromatographic method with column switching has been developed for the determination of rifapentine in serum. The serum samples were injected onto a precolumn packed with Corasil RP C18 (37-50 microns) after simple dilution with an internal standard in a 1% ascorbic acid solution. Polar serum components were washed out using 0.05 M phosphate buffer. After valve switching, the concentrated drugs were eluted in the back-flush mode and separated by a mu Bondapak C18 column with acetonitrile-tetrahydrofuran-0.05 M phosphate buffer (pH 7.0) (42:5:53, v/v/v) as the mobile phase. The method showed excellent precision with good sensitivity and speed, and a detection limit of 0.1 microgram/ml. The total analysis time was less than 25 min and the mean coefficients of variation for intra- and inter-assay were less than 4.8%. The method has been successfully applied to serum samples from dogs after the oral administration of rifapentine.     

反相高效液相法测定血清中的佐匹克隆

 建立了测定血清中佐匹克隆的反相高效液相法 (外标法 )。血样用正丁基氯提取后进行分离。采用的柱为LiChroCART 12 5 4柱 (LiChrospher 6 0RPselectB填料 ,5 μm ,12 5mm× 4mmi d ) ,流动相为乙腈 0 0 2mol/LKH2 PO4缓冲溶液 (体积比为 2 0∶80 ) ,紫外检测波长为 2 5 4nm。当佐匹克隆在血清中的添加质量浓度分别为 4 0 0 μg/L ,16 0 0 μg/L和6 4 0 0 μg/L时 ,血清中佐匹克隆的回收率分别是 (73 4± 3 2 ) % ,(82 2± 4 1) %和(90 3± 4 5 ) %。方法的最低检出限为 15 μg/L。方法适用于法庭毒物分析 ,简便、快速。     

High performance liquid chromatographic determination of Picumast and two active metabolites in plasma using on-line sample preparation.

A method for determining Picumast, an antiallergic drug, in plasma by HPLC and column switching has been developed. The system consisted of two precolumns, an analytical column, three pumps, an autosampler and a fluorescence detector. The precolumns (17 x 4.6 mm i.d.) were packed with LiChroprep RPR (a moderately polar reversed phase) and the analytical column with Nucleosil ODS (RP 18, 5 microns). The columns were connected according to the alternating precolumn technique. The mobile phase consisted of 30% CH3CN/70% 0.05 M KH2PO4, pH 2.5, with a flow gradient. Detection wavelengths were 333 nm for excitation and 383 nm for emission. The retention times of Picumast, M1 and M2 were 12, 3.6 and 4.0 min, respectively. Total run time was 15 min. The limit of detection was 3 ng/mL for M1 and 1 ng/mL for M2 and Picumast using an injection volume of 150 microL. The recoveries vary between 89% and 97% with standard deviations between 2.4 and 3.3%.     

Identification of the factors that influence the reproducibility of chromatographic retention data

Principal component analysis was used to identify the parameters that influence the column-to-column and batch-to-batch reproducibility of retention times and retention factors measured on Symmetry C18, Kromasil C18, Luna C18 (2) and Vydac RP C18, all reversed-phase silica columns. We devised a procedure that allows the determination of the differences in column volume and packing density between two columns, provided that these columns are packed with identical stationary phases (i.e., phases that originate from the same batch). Principal component analysis of the retention times confirmed that the column-to-column variations of the column volume and the total porosity of the bed are the factors that influence the reproducibility of the retention times, the column volume being the major factor. For the fluctuations of the retention factors, the column phase ratios (or the bed porosities) and some specific, secondary retention mechanisms are responsible. All the C18 columns investigated proved to behave in a very similar fashion. Two principal components were always sufficient to characterize the variations of either the retention times or the retention factors.     

Simultaneous determination of cefamandole and cefamandole nafate in human plasma and urine by high-performance liquid chromatography with column switching

A high-performance liquid chromatographic method with column switching has been developed for the simultaneous determination of cefamandole and cefamandole nafate in plasma and urine. The plasma and urine samples were injected onto a precolumn packed with Corasil RP C18 (37-50 microns) after simple dilution with an internal standard solution in 0.05 M phosphoric acid. Polar plasma and urine components were washed out using 0.05 M phosphoric acid. After valve switching, the concentrated drugs were desorbed in back-flush mode and separated by a reversed-phase C8 column with methanol-5 mM tetrabutylammonium bromide (45:55, v/v) as the mobile phase. The method showed excellent precision with good sensitivity and speed, and a detection limit of 0.5 microgram/ml. The total analysis time per sample was less than 30 min, and the mean coefficients of variation for intra- and inter-assay were both less than 4.9%. The method has been successfully applied to plasma and urine samples for human volunteers after intravenous injection of cefamandole nafate.     

一种混合模式反相弱阳离子交换色谱填料的制备及其保留机理

采用“点击化学”的合成方法制备了一种混合配体的辛基-羧基共同键合硅胶（OCS）材料,经元素分析和红外光谱表征,证明了辛基和羧基官能团均已成功键合到硅胶表面。将其作为混合模式反相弱阳离子交换（RP/WCX）的固定相填料,以3种同系物阳离子表面活性剂作为探针分子,定量研究了该固定相的混合模式保留机理,考察了溶质保留因子与盐浓度和溶质亚甲基数目的关系,验证了混合模式固定相的单点和两点保留机理的数学模型,并进一步将其应用于一系列标准碱性混合物的分离。结果表明：两点保留机理更加符合实验的结果;根据混合模式两点保留机理的数学方程,可以得到单一的疏水或离子交换作用力对总保留的影响,对混合模式色谱的实际分离应用提供了有价值的参考。本文建立了反相弱阳离子交换混合模式OCS固定相的保留机理的定量模型,并证明了该固定相在碱性化合物的分离中具有很大的应用前景。